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Letter to the Editor
TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE IN HAIRY-CELL
LEUKAEMIA AND HODGKIN'S DISEASE
SIR,-Although high terminal deoxynucleo-
tidyl transferase (TdT) activity can be easily
shown in thymus, acute lymphoblastic leu-
kemia (ALL) cells, ALL cell lines and some
cases of both acute myelogenous and blastic-
phase chronic myelogenous leukaemia
(McCaffery et al., 1975; Sarin et at., 1976;
Hutton & Coleman, 1976; Srivastava, et al.,
1977; Srivastava et al., 1976; Minowada et al.,
1978) there is still doubt about its presence
in other cells containing apparently low
TdT activity (Srivastava & Minowada, 1976)
which is difficult to demonstrate. In our
examination of 11 Hodgkin's disease (HD)
and 4 hairy-cell leukaemia (HCL) patients,
we have found 1 patient in each of these
categories where TdT activity could be con-
vincingly demonstrated. The estimations of
DNA polymerase ac + ,B (DP) activity on the
whole-cell homogenate with activated DNA
as the template, and of TdT after glycerol-
gradient fractionation and using dA12_18
initiator 0-5mM MnCl2 and 100 JiM
[3H]-dGTP (sp. act. 1-4 Ci/mmol) were carried
out according to our published procedures
(Srivastava et at., 1977). Both DP and TdT
activities were expressed as units/mg DNA,
where 1 unit equals 1 nmol of [3H]-dGMP
polymerized in 1 h. Although HCL patient
H.M. (TdT, 1-5 units in peripheral blood and
0-73 units in spleen) and nodular-sclerosis-
type HD patient M.O. (TdT, 0-69 units in
spleen) had definite activity, other patients
among both HCL (TdT 0-08 - 0-22, mean =
0-13) and HD with nodular sclerosis or
mixed cellularity (TdT, 0-02 - 0-17, mean =
0-07) also had detectable activity. As from
other cells (Srivastava et al., 1977) the TdT
from patients H.M. and M.O. was not re-
tained by DEAE-Sephadex A-25, was eluted
from phosphocellulose column at 0-4M NaCI,
was not inhibited by 0-25M NaCl but was
strongly inhibited ( > 80%) by 10mM N-
ethyl-maleimide, 200 ,ug/ml of streptolydigin
or 100 ,ug of anti-TdT, and was completely
destroyed on heating for 6 min at 50TC. No
significant differences in DP activity between
patient H.M. (27 units in peripheral blood
and 19 units in spleen) and other HCL
patients (range 5-21 units, mean = 10) or
betweenM.0. (29units) andother HDpatients
(range 11-33 units, mean = 21) were noted.
The results presented here clearly demon-
stratethatdefiniteTdTactivity, asinH.M.and
M.0. can be found in peripheral blood and
spleen from HCL and HD patients. However,
this TdT activity was of the same order of
magnitude as that found in B-cell lines
(Srivastava, 1976) and was significantly
lower than the high TdT activity (20-200 u/
mg DNA) found in thymus, ALL and other
cells mentioned earlier (Srivastava et al.,
1976, 1977; Minowada et al., 1977).
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